Pharmaceutical Biotechnology – Drug Discovery and Clinical Applications
Wiley-VCH Verlag GmbH (Hersteller)
978-3-527-60241-4 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
Professor Langer is member of all three national academies - the Institute of Medicine, the National Academy of Engineering, and the National Academy of Sciences: 'The book attempts to provide a balanced view of the biotechnological industry and the number of experts from industry sharing their knowledge and experience with the audience gives the book an outstanding value. All contributors provide with each chapter an up-to-date review on key topics in pharmaceutical biotechnology. This work is not only a valuable tool for the industrial expert but also for all pharmacists and scientists from related areas who wish to work with biotech drugs.'
Oliver Kayser: Oliver Kayser received his PhD at the Free University Berlin in 1997 following his fellowship at the University of Gainesville, Florida, whereupon he entered the pharmaceutical biotechnology industry. He is currently a lecturer at the Department of Pharmaceutics, Biopharmacy and Biotechnology at the FU Berlin, working on new biotech drugs from natural sources and on the development of drug delivery carriers based on nanosuspension and solid lipid nanoparticle enterprise technologies. Rainer H. Muller: Professor Muller is Head of the Department of Pharmaceutical Technology, Biotechnology & Quality Management at the Free University Berlin. His research focuses on solid lipid nanoparticles, nanosuspensions of poorly soluble drugs and drug targeting using the concept of "differential protein adsorption". He obtained his PhD at Kiel University in 1983, and spent 4 years as visiting scientist at the Pharmacy Department, University of Nottingham, UK and 1 year at the Universite de Paris--Sud.
PART 1. INTRODUCTION TO CONCEPTS AND TECHNOLOGIES IN PHARMACEUTICAL BIOTECHNOLOGY A Primer on Pharmaceutical Biotechnology and Industrial Applications (Kayser, Muller) Procaryotic and Eucaryotic Cells in Biotech Production (Bechthold) Biopharmaceuticals Expressed in Plants (Knablein) PART 2. INDUSTRIAL DEVELOPMENT AND PRODUCTION PROCESS Scientific, Technical and Economic Aspects of Vaccine Research and Development (Gregersen) DNA Vaccines: From Research Tools in Mice to Vaccines in Humans (Ulmer) Characterisation and Bioanalytical Aspects of Recombinant Proteins as Pharmaceutical Drugs (Haunschild) Biogeneric Drugs (Hinderer) PART 3. THERAPEUTIC PROTEINS -- SPECIAL PHARMACEUTICAL ASPECTS Pharmacokinetics and Pharmacodynamics of Biotech Drugs (Meibohm) Formulation of Biotech Drugs (Lipp) Patents in Biotechnology Industry: Legal and Ethical Issues (Resnick) Drug Approval in the EU und US (Walsh) PART 4. BIOTECH 21 -- INTO THE NEXT DECADE Rituximab (Grillo) Somatic Gene Therapy (Gottschalk) Non Viral Gene Delivery Systems (Kayser) Xenotransplantation in Pharmaceutical Biotechnology (Brunn) Sculpturing the Architecture of Mineralized Tissues: Tissue Engineering of Bone from Soluble Signals to Smart Biomimetic Matrices (Ripamonti) INDEX
| Erscheint lt. Verlag | 28.1.2005 |
|---|---|
| Verlagsort | Weinheim |
| Sprache | englisch |
| Maße | 130 x 250 mm |
| Gewicht | 666 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Naturwissenschaften ► Biologie ► Biochemie | |
| Technik | |
| ISBN-10 | 3-527-60241-0 / 3527602410 |
| ISBN-13 | 978-3-527-60241-4 / 9783527602414 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
